Senate committee to vote on Dr. Oz’s nomination to run Medicare and Medicaid services
The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote.
The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.
If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.
HAWLEY SKEPTICAL OF TRUMP PICK OZ: ‘I HOPE HE’S CHANGED HIS VIEWS’
Dr. Mehmet Oz testifyies at his confirmation hearing before the Senate Finance Committee, on Capitol Hill, March 14, 2025. (AP Photo/Ben Curtis)
A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of “The Dr Oz Show,” Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor.
Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.
As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.
DR. OZ BATS BACK DEMOCRATIC ATTEMPTS TO PAINT HIM AS A ‘SNAKE OIL’ SALESMAN IN SENATE HEARING
Dr. Mehmet Oz greets Sen. Marsha Blackburn before his Senate Finance Committee confirmation hearing on Capitol Hill, March 14, 2025. (AP Photo/Ben Curtis)
Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate.
Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation.
On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.
